Apollo Hospitals to spin off digi health, pharmacy business

Apollo Hospitals is demerging its omnichannel pharma and digital health businesses into a new entity, aiming for a separate listing. This move creates India's largest omnichannel pharmacy platform with a revenue target of ₹25,000 crore by FY27. The promoter family will hold approximately 36.5% in the new company, with Shobana Kamineni as the executive chairperson.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yzOGd41
via IFTTT

Read More

Wockhardt activates Zaynich push, eyes global licensing deals

Wockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions in the US and India. The company is exploring out-licensing deals while preparing for potential solo commercialization in key markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AQmcYDl
via IFTTT

Read More

After a robust march, pharma exports slow

India's pharmaceutical exports experienced a modest 1.5% growth in April and May, following a significant 31.2% surge in March driven by year-end targets and anticipation of US tariffs. Despite pricing pressures and regulatory scrutiny, shipments to the US rose 20.4% to $10.5 billion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/U6crY4N
via IFTTT

Read More

Torrent Pharma set to finalise JB Chemicals buyout in 15-18 months

Torrent Pharmaceuticals is set to acquire JB Chemicals & Pharmaceuticals, with the deal expected to finalize in 15-18 months, pending regulatory approvals. The acquisition, primarily debt-funded, aims to enhance Torrent's presence in the Indian market, particularly in high-growth segments like cardiac and gastroenterology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BtDPmXi
via IFTTT

Read More

Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injection

Alembic Pharmaceuticals has received final USFDA approval. This approval is for its generic Doxorubicin Hydrochloride Liposome injection. The injection comes in strengths of 20 mg/10 mL and 50 mg/25 mL. It is used to treat ovarian cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma. The market size for this injection is estimated at USD 29 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CWsE2vP
via IFTTT

Read More

Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuation

Torrent Pharma will acquire a controlling stake in JB Chemicals from KKR. The deal values JB Chemicals at Rs 25,689 crore. This merger will elevate Torrent to fifth position in the Indian pharmaceutical market. KKR is expected to gain a fivefold return on its 2020 investment. The combined entity aims for significant revenue and profitability growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dNEK69B
via IFTTT

Read More

Clear & Legible: Labelling on drug packets to get a booster

Concerns arose regarding medicine labels. Consumers struggled to read expiry dates. The shiny surface of strips posed readability issues. The Drugs Consultative Committee addressed the matter. A sub-committee will examine packaging in detail. They will assess regulations for packaging suppliers. The government considers voice-assisted QR codes. Braille cards on strips are also under consideration.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lFbvXEj
via IFTTT

Read More